
Helus Pharma appoints Jill Conwell as Chief People Officer
Lucy Batizovsky | March 16, 2026 | Appointment | | Helus Pharma
Helus Pharma, a clinical stage pharmaceutical company focussed on developing novel serotonergic agonists (NSAs), has appointed Jill Conwell as Chief People Officer, effective immediately.
Bringing over 20 years of leadership experience to the role, Conwell has previously held senior leadership roles at Aclaris Therapeutics, Idera Pharmaceuticals and Shire Pharmaceuticals.
Conwell said: “Helus Pharma is advancing an innovative approach to addressing serious mental health conditions, and I value the opportunity to help the team execute on our scientific and strategic goals while maintaining a strong, collaborative and mission-driven culture.”
Michael Cola, Chief Executive Officer of Helus Pharma, said: “Jill has a proven ability to help life sciences companies build and align teams, organisational strategies, and processes to support ambitious growth.
“As Helus Pharma advances our clinical programmes and prepares for the next phase of growth, Jill’s experience will be invaluable in helping us attract top talent, advance our culture, and scale the organisation to support the business.”






